Cladribine tablets produce selective and discontinuous reduction of B and T lymphocytes and natural killer cells in patients with early and relapsing multiple sclerosis (ORACLE-MS, CLARITY and CLARITY Extension)

被引：0
|
作者：
Stuve, O. [1 ]
Soelberg-Sorensen, P. [2 ]
Giovannoni, G. [3 ]
Leist, T. [4 ]
Hyvert, Y. [5 ]
Damian, D. [5 ]
Boschert, U. [5 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen, Denmark
[3] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[4] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
[5] EMD Serono Inc, Billerica, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P690
引用
收藏
页码：335 / 336
页数：2
相关论文
共 37 条
  • [1] Cladribine tablets produce selective and discontinuous reduction in B and T lymphocytes and natural killer cells in patients with early and relapsing multiple sclerosis (ORACLE-MS, CLARITY and CLARITY extension)
    Stuve, Olaf
    Soelberg-Sorensen, Per
    Giovannoni, Gavin
    Leist, Thomas
    Hyvert, Yann
    Damian, Doris
    Boschert, Ursula
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP6 - NP6
  • [2] Selective and discontinuous reduction of B and T lymphocytes by cladribine tablets in patients with early and relapsing multiple sclerosis (ORACLE-MS, CLARITY and CLARITY Extension)
    Stuve, Olaf
    Soelberg-Sorensen, Per
    Giovannoni, Gavin
    Leist, Thomas
    Hyvert, Yann
    Damian, Doris
    Boschert, Ursula
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP11 - NP11
  • [3] Selective and discontinuous reduction of B and T lymphocytes by cladribine tablets in patients with early and relapsing multiple sclerosis (ORACLE-MS, CLARITY and CLARITY Extension)
    Stuve, O.
    Soelberg-Sorensen, P.
    Giovannoni, G.
    Leist, T.
    Hyvert, Y.
    Damian, D.
    Boschert, U.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 413 - 414
  • [4] Selective and Discontinuous Reduction of B and T Lymphocytes and NK Cells in Patients with Early and Relapsing MS (ORACLE-MS, CLARITY and CLARITY Extension) after Administration of Cladribine Tablets
    Stuve, Olaf
    Soerensen, Per Soelberg
    Giovannoni, Gavin
    Leist, Thomas
    Hyvert, Yann
    Damian, Doris
    Boschert, Ursula
    NEUROLOGY, 2018, 90
  • [5] Cladribine tablets produce selective and discontinuous reduction of B and T lymphocytes and natural killer cells in patients with early and relapsing Multiple Sclerosis
    Stuve, O.
    Soelberg-Sorensen, P.
    Giovannoni, G.
    Leist, T.
    Hyvert, Y.
    Damian, D.
    Boschert, U.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 527 - 527
  • [6] Selective and Discontinuous Reduction of B and T Lymphocytes and NK Cells by Cladribine Tablets in Patients with Early and Relapsing MS
    Stuve, O.
    Soelberg-Sorensen, P.
    Giovannoni, G.
    Leist, T.
    Hyvert, Y.
    Damian, D.
    Boschert, U.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 397 - 398
  • [7] NEDA-3 durability in CLARITY Extension in patients with relapsing multiple sclerosis receiving cladribine tablets
    Giovannoni, G.
    Keller, B.
    Jack, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 492 - 493
  • [8] Durability of NEDA-3 status in patients with relapsing multiple sclerosis receiving cladribine tablets: CLARITY Extension
    Giovannoni, Gavin
    Keller, Birgit
    Jack, Dominic
    NEUROLOGY, 2019, 92 (15)
  • [9] Durability of NEDA-3 status in patients with relapsing multiple sclerosis receiving cladribine tablets: CLARITY extension
    Giovannoni, G.
    Keller, B.
    Jack, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 479 - 480
  • [10] Durability of NEDA-3 Status in Patients with Relapsing Multiple Sclerosis Receiving Cladribine Tablets: CLARITY Extension
    Giovannoni, Gavin
    Keller, Birgit
    Jack, Dominic
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 47 - 48
1234